These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26385324)

  • 1. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
    Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
    J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
    Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
    Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
    Berlato D; Murphy S; Laberke S; Rasotto R
    Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S; Bettini G
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine Cutaneous Mast Cell Tumours Exhibit Variable Differentiation, Proliferation Activity and KIT Expression.
    Ressel L; Ward S; Kipar A
    J Comp Pathol; 2015 Nov; 153(4):236-43. PubMed ID: 26292768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic.
    Gil da Costa RM
    Vet J; 2015 Jul; 205(1):5-10. PubMed ID: 26021891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline cutaneous mast cell tumours: a UK-based study comparing signalment and histological features with long-term outcomes.
    Melville K; Smith KC; Dobromylskyj MJ
    J Feline Med Surg; 2015 Jun; 17(6):486-93. PubMed ID: 25193279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
    Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
    J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
    Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
    Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
    Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
    Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of the Pluripotency Factor OCT4 in Canine Mast Cell Tumours.
    Vargas TH; Pulz LH; Barra CN; Kleeb SR; Xavier JG; Catão-Dias JL; Fukumasu H; Nishiya AT; Strefezzi RF
    J Comp Pathol; 2015 Nov; 153(4):251-5. PubMed ID: 26460092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic characteristics and KIT staining patterns of equine cutaneous mast cell tumors.
    Clarke L; Simon A; Ehrhart EJ; Mulick J; Charles B; Powers B; Duncan C
    Vet Pathol; 2014 May; 51(3):560-2. PubMed ID: 23794148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
    Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
    BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.